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Abstract
Introduction: Hyperlipidemia is prevalent and is highly associated with coronary heart disease. Some patients are
reluctant or opt not to take lipid-lowering prescription medications for fear of adverse drug reactions. There are
currently few well-designed randomized controlled trials showing the possibility of reducing cholesterol using red
yeast rice. Meanwhile, adverse effects have also been reported.
Case presentation: A 64-year-old Asian man was diagnosed with hyperlipidemia despite a healthy lifestyle. In
addition to diet changes, the patient used red yeast rice and succeeded in lowering his level of serum lipids.
Conclusion: Based on this case and a review of current literature, in addition to therapeutic lifestyle change, red
yeast rice may be a useful alternative treatment for primary hyperlipidemia in patients with low cardiac risk and
who refuse to take any lipid-lowering prescription medication or who maybe be statin intolerant.
However, primary care physicians must be aware of the potential side effects of taking red yeast rice.
Introduction
Hyperlipidemia is highly prevalent. It is closely related
to coronary heart disease which is the most common
cause of death in the United States [1]. Approximately
52 million adults require lifestyle modifications includ-
ing dietary changes and exercises, and 13 million adults
need lipid-lowering medications to control their low-
density lipoprotein (LDL) levels [2].
Primary care physicians are faced with many chal-
lenges in treating hyperlipidemia. Lifestyle modification
alone is often unsuccessful in decreasing low-density
lipoprotein (LDL) levels. In addition, patients who
require lipid-lowering agents are oftentimes non-compli-
ant, which is partially due to their fear of any adverse
effects. It has been shown that roughly 50% of patients
taking lipid-lowering drugs discontinue their medication
after one year, and 75% stop after two years [3].
The growing mistrust of the general public on the
pharmaceutical industry also contributes to the decision
of patients not to take prescription lipid-lowering drugs.
As a result, patients seek alternative drugs or opt to rely
on natural therapy in order to control their
hypercholesterolemia.
This case highlights a possible alternative treatment
for hyperlipidemia for patients who are unwilling to take
prescription lipid-lowering drugs but who are at a mini-
mal risk of developing coronary artery diseases.
Case presentation
A 64-year-old Asian man who was previously healthy
and had no comorbidity presented for his annual physi-
cal examination. He was not taking any medications
except for his daily multivitamins. He also indicated on
many occasions that he would not take any prescription
medications unless it was for treating a life-threatening
condition.
His history and physical examination were unremark-
able. His family history only included diabetes mellitus
type 2 on his maternal side. He ate a balanced diet,
exercised regularly, and actively got involved his com-
munity. He did not smoke and only drank a glass of red
wine once a week. His blood pressure was normoten-
sive, his body mass index (BMI) was normal, and all
preventive measures he underwent were up-to-date. A
routine blood work was done on that visit to identify
the patient’s comprehensive blood count (CBC), com-
prehensive metabolic panel (CMP), lipid panel, thyroid
function test, and prostate-specific antigen (PSA). * Correspondence: jslin2@emory.edu
Geriatric Research Education and Clinical Center, Atlanta Veterans Affairs
Medical Center, Clairmont Road, Decatur Georgia 30033, USA
Lin Journal of Medical Case Reports 2010, 4:4
http://www.jmedicalcasereports.com/content/4/1/4 JOURNAL OF MEDICAL
CASE REPORTS
© 2010 Lin; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.The patient was phoned and informed of his blood
work results three days later. His blood work was unre-
markable except for the lipid panel which showed a
total cholesterol level of 260, a low-density lipoprotein
(LDL) level of 202, a high-density lipoprotein (HDL)
level of 40, and a triglyceride level of 179. Based on his
calculated 10-year total coronary heart disease risk, he
was recommended to continue his regular exercises and
make further dietary changes to induce more omega-3
and to cut down on total fat intake. He was also advised
to return to the clinic after three months to repeat the
lipid panel test.
The patient returned to the clinic three months later
for his follow-up evaluation for hyperlipidemia. His vital
signs and the results of his physical examination were
unchanged from his previous presentation. However, he
stated that in addition to dietary changes, he had also
begun taking an over-the-counter dietary supplement of
600 mg of red yeast rice(brand name: Schiff) twice daily
with meals for about 12 weeks after he learned that his
cholesterol levels were high. He used it because he
t h o u g h ti tw a sm o r e“natural”. A repeated lipid panel
test surprisingly showed a reduction in his total choles-
terol level (198), LDL level (155), and triglyceride level
(146). Meanwhile, his HDL level was unchanged.
This patient returned to the clinic one more time
three months later for his reevaluation for hyperlipide-
mia. Again, his vital signs and the results of his physical
examination were unremarkable. While continuing on a
regular exercise regimen of moderate intensity, a heal-
thier diet, and the red yeast rice supplement, his lipid
panel remained stable and satisfactory. His total choles-
terol was found to be 190, LDL level was 152, triglycer-
ide level was 142, and high- HDL level was 45.
Discussion
Red yeast rice, a substance made by fermenting a type of
red yeast called Monascus purpureus,h a sb e e nu s e df o r
centuries in China as a type of seasoning. It has also
been used in traditional Chinese medicine as a remedy
to improve circulation and alleviate indigestion and diar-
rhea [4]. In recent years, it has been established by
scientists as a potentially useful product that aids in
lower serum lipids, including cholesterol and
triglyceride.
Researchers found that red yeast rice contains natu-
rally-occurring monacolin, an active ingredient in the
popular statin drug, lovastatin. Lovastatin inhibits
HMG-CoA reductase, an enzyme that is important in
synthesizing cholesterol in the body [4].
At present only a few well-designed randomized con-
trolled trials using red yeast rice as a cholesterol lower-
ing agent have been designed. One recent study
demonstrated that red yeast rice and lifestyle
modification can decrease LDL levels without increasing
creatinine phosphokinase (CPK) or pain levels. It was
also noted as a viable treatment alternative for patients
with hypercholesterolemia who cannot tolerate statin
therapy. The authors also pointed out that red yeast rice
supplement used by the patients in their study con-
tained naturally occurring lovastatin that is equivalent to
about a 6 mg of daily dose. Because this is such a small
dose, it was postulated that there might be something
other than monacolin that may inhibit HMG-CoA
reductase in red yeast rice [5]. One study also showed
that lifestyle modifications coupled with the ingestion of
red yeast rice and fish oil were as good in lowering LDL
as taking simvastatin for 12 weeks [6]. A meta-analysis
of randomized controlled trials indicated that the effects
of red yeast rice in lowering total cholesterol, triglycer-
ide and LDL levels were more significant than placebo
but similar to the effects of pravastatin, simvastatin,
lovastatin, atorvastatin, or fluvastatin [7].
However, just because red yeast rice is natural and
viewed as a dietary supplement does not mean that it is
safe and without any adverse effects. A case of acute
hepatitis was reported after a patient took an over-the-
counter lipid-lowering product containing red yeast rice
and the liver function test returned to normal only after
the supplement was discontinued [8,9]. Another com-
monly reported adverse effect of red yeast rice is myo-
pathy [10,11].
Conclusion
Based on this case and a review of current literature, it
would be advisable for primary care physicians to pre-
scribe therapeutic lifestyle change and to ask patients to
consider using red yeast rice as a useful alternative
treatment for primary hyperlipidemia in patients with
low cardiac risk and who refuse to take any lipid-lower-
ing prescription medication or who maybe be statin
intolerant. It must be realized, however, that the choles-
terol improvement seen in this case could be multifac-
torial, and that the potential of lifestyle modification
alone should not be undermine. It must also be remem-
bered that some of the potential adverse effects of sta-
tins, including acute hepatitis and myopathies, can also
occur in patients using red yeast rice. Therefore, it
would be helpful to discuss this with patients prior to
starting them on red yeast rice treatment. As with statin
prescription, precautions such as checking the patient’s
liver and renal functions should also be observed. It
should also be noted that just like statins, pregnant or
nursing women should avoid ingesting red yeast rice.
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